⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11107953 | 0.87 | MEN1 (0.52) | — | |
| SCHEMBL5487957 | 0.87 | MEN1 (0.52) | — | |
| SCHEMBL11103862 | 0.87 | MEN1 (0.52) | — | |
| Hydrochloric Acid SCHEMBL28371398 | 0.85 | MEN1 (0.50) | — | |
| Benzene SCHEMBL28173940 | 0.82 | MEN1 (0.48) | — | |
| Propane SCHEMBL28437167 | 0.76 | MEN1 (0.44) | — | |
| SCHEMBL441370 | 0.76 | ALDH1A1 (0.41) | — | |
| SCHEMBL2448057 | 0.74 | MEN1 (0.43) | — | |
| SCHEMBL4298276 | 0.74 | ALDH1A1 (0.43) | — | |
| SCHEMBL14873967 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028342-A1 | ENHANCING ANTIMETASTASIS ACTIVITY USING TARGETED PROTEIN DEGRADATION | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2026-01-29 | — | — | US | disclosed |
| US-12479813-B2 | Method of therapeutically treating cancer | ADT PHARMACEUTICALS, LLC (US) | 2025-11-25 | — | — | US | disclosed |
| WO-2024233665-A1 | COMPOUNDS AND THEIR USE AGAINST CANCER | TANGO THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024233605-A1 | COMPOUNDS AND THEIR USE AGAINST CANCER | TANGO THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | disclosed |
| US-20240294478-A1 | ANTI-CANCER COMPOUNDS AND METHODS OF USE | UNIV YALE (US) | 2024-09-05 | — | — | US | disclosed |
| US-20240182481-A1 | PYRROLO[3,2-D]PYRIMIDINE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER | TANGO THERAPEUTICS, INC. | 2024-06-06 | — | — | US | disclosed |
| US-20240059689-A1 | PURINE DERIVATIVES AS ANTICANCER AGENTS | MEDIVIR AB (SE) | 2024-02-22 | — | — | US | disclosed |
| WO-2024026064-A1 | ENHANCING ANTIMETASTASIS ACTIVITY USING TARGETED PROTEIN DEGRADATION | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-4308566-A1 | PURINE DERIVATIVES AS ANTICANCER AGENTS | Tango Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4291559-A1 | PYRROLO[3,2-D]PYRIMIDINE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER | Tango Therapeutics, Inc. (US) | 2023-12-20 | — | — | EP | disclosed |
| WO-2013090912-A1 | COMPOUNDS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-06-20 | — | — | WO | disclosed |
| WO-2012148889-A1 | INHIBITORS OF HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE 1 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012024367-A2 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL | DEL MAR PHARMACEUTICALS (CA) | 2012-02-23 | — | — | WO | disclosed |
| EP-0840608-A4 | TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES | CONSTANTIA GRUPPE (AT) | 2002-10-02 | — | — | EP | disclosed |
| US-5912346-A | Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles | CONSTANTIA GRUPPE (AT) | 1999-06-15 | — | — | US | disclosed |
| US-5861406-A | ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS | CONSTANTIA GRUPPE (AT) | 1999-01-19 | — | — | US | disclosed |
| EP-0840608-A1 | TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES | Constantia Gruppe (AT) | 1998-05-13 | — | — | EP | disclosed |
| US-5728707-A | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide | CONSTANTIA GRUPPE (AT) | 1998-03-17 | — | — | US | disclosed |
| WO-1997003668-A1 | TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES | CONSTANTIA GRUPPE (AT) | 1997-02-06 | — | — | WO | disclosed |
| US-3956262-A | BACTERICIDES, FUNGICIDES, ANTITUMOR | BEECHAM GROUP LIMITED (UK) | 1976-05-11 | — | — | US | disclosed |